Pectolinarigenin acts as a potential anti-osteosarcoma agent via mediating SHP-1/JAK2/STAT3 signaling
Open Access
- 22 June 2022
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 153, 113323
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Roles of STAT3 and ZEB1 Proteins in E-cadherin Down-regulation and Human Colorectal Cancer Epithelial-Mesenchymal TransitionJournal of Biological Chemistry, 2012
- The Molecular Pathogenesis of Osteosarcoma: A ReviewSarcoma, 2011
- Silencing of Autocrine Motility Factor Induces Mesenchymal-to-Epithelial Transition and Suppression of Osteosarcoma Pulmonary MetastasisCancer Research, 2010
- Betulinic acid suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase SHP‐1 in human multiple myeloma cellsInternational Journal of Cancer, 2009
- Characterization of STAT3 activation and expression in canine and human osteosarcomaBMC Cancer, 2009
- Osteosarcoma incidence and survival rates from 1973 to 2004Cancer, 2009
- The Role of STAT-3 in the Induction of Apoptosis in Pancreatic Cancer Cells by Benzyl IsothiocyanateJNCI: Journal of the National Cancer Institute, 2009
- Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft miceBMC Cancer, 2007
- Persistent Activation of Stat3 Signaling Induces Survivin Gene Expression and Confers Resistance to Apoptosis in Human Breast Cancer CellsClinical Cancer Research, 2006
- The role of IL-6 and STAT3 in inflammation and cancerEuropean Journal of Cancer, 2005